尼姆玻利德:预防和治疗慢性疾病的有希望的药物 (最近的更新)
Peramaiyan Rajendran1,2, Kaviyarasi Renu2, Basem M Abdallah1
1Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
Food & nutrition research
|April 4, 2024
概括
尼姆树的化合物尼姆玻利德 (Nimbolide) 由于其抗炎和抗癌作用,对治疗慢性疾病充满希望. 研究强调了其调节关键分子通路的能力,这些通路涉及到诸如心血管疾病和癌症等疾病.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
- 慢性疾病管理 慢性疾病管理
背景情况:
- 尼姆树 (Azadirachta indica) 的生物活性化合物Nimbolide具有显著的抗炎,抗氧化和抗癌特性.
- 传统上在医学中使用,Nimbolide正在研究其在管理慢性疾病的潜力,如心血管疾病,糖尿病和癌症.
- 最近的研究强调了尼姆博莱德的多方面的药理作用,将其定位为有前途的治疗剂.
研究的目的:
- 在慢性疾病中审查尼姆博莱德治疗效应的分子机制.
- 巩固当前关于尼姆博莱德有效性和在疾病预防和治疗中的潜在应用的研究.
- 探索 nimbolide 在调节慢性疾病相关的关键信号通路中的作用.
主要方法:
- 在包括MEDLINE,Embase,Scopus和知识网络在内的主要数据库中进行了全面的文献搜索.
- 搜索的重点是到2020年9月发表的研究.
- 该审查集中在了解尼姆博莱德治疗作用的分子机制上.
主要成果:
- 尼姆树中的一种强效的利莫诺伊德Nimbolide调节了关键的信号通路,如MAPKs,Wnt-β/catenin,NF-κB和PI3K/AKT.
- 它影响信号分子,包括TGF-β,MMP,VEGF,炎症细胞因子和EMT蛋白.
- 尼姆玻利德具有抗炎,抗微生物和抗癌特性,在骨关节炎,类风湿性关节炎,心血管疾病和癌症中显示出治疗潜力.
结论:
- 尼姆玻利德是一种有前途的天然化合物,具有治疗一系列慢性疾病的巨大潜力.
- 它的有效性源于其调节关键分子和信号通路的能力,这些通路参与了疾病的发病.
- 对尼姆博莱德分子机制的进一步研究可以为创新的治疗策略铺平道路.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
162
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116


